This story has been updated to include additional information about the tests being performed.
NEW YORK — Clinical genomic testing company Sema4 said on Monday that it has signed an agreement with Connecticut to provide SARS-CoV-2 viral and antibody testing to state residents including state employees, first responders, long-term care facility residents, and patients requiring care at primary care facilities.